In ‘Challenging’ Year, CICC Leads Chinese Equity Sales
Free Trial
Institutional Investor Research is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Results
Sales Teams
China Sales Team

In ‘Challenging’ Year, CICC Leads Chinese Equity Sales

Alexandra DeLuca
November 06, 2018
chinasales.jpg

Both international and domestic investors chose China International Capital Corp. as the No. 1 firm in II’s 2018 All-China Sales Team.

Register (free), subscribe or login to access this page:

Unlock essential data and insights

      • Register (free) for top line Survey Results and most Editorial content
      • Subscribe for full access to our unique data and premium editorial
Register or Subscribe Now Already registered/subscribed? Login now

Topics

China Research ProvidersChina Sales Team
authorgeneric.png
Alexandra DeLuca

Related

China Research Providers
art-joint1stplaceresearch-0112-1.jpg
The Research Firms Navigating a Muted China Reopening
The buy-side once again recognized UBS and CICC as No. 1 in II’s annual ranking of the country’s sell-side research providers.
Alexandra DeLuca, January 15, 2024
China Research Providers
art-chinareopening-0109.jpg
What Top Research Providers Expect from China’s Reopening
As China pivots, the country could serve as a “haven” for investors seeking growth.
Grace Chung, January 09, 2023
China Research Providers
art-ch1-0112.jpg
It Was a Rocky Year for Chinese Investors. Here’s Where They Looked for Answers.
CICC and UBS lead II’s 2021 All-China Research Team.
Alexandra DeLuca, January 12, 2022
Gift this article